20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T14116 | ACP-105 | Androgen Receptor | |
ACP-105 is a novel and potent nonsteroidal selective androgen receptor modulator (SARM) with partial agonist activity relative to the natural androgen testosterone. | |||
T2076 | Pimavanserin | ACP-103 | 5-HT Receptor |
Pimavanserin (ACP-103)(ACP-103) is an effective and specific 5-HT2A receptor inverse agonist (mean pIC50: 8.7, in the cell-based functional assay). Pimavanserin is an atypical antipsychotic used in the treatment of hallu... | |||
T6946 | Pimavanserin tartrate | ACP-103,ACP-103 tartrate,Nuplazid,Pimavanserin | 5-HT Receptor |
Pimavanserin tartrate (Nuplazid) is an effective and specific serotonin 5-HT2A inverse agonist (pIC50: 8.73), used in the therapy of psychosis associated with Parkinson's disease. | |||
T3626 | Acalabrutinib | ACP-196 | BTK |
Acalabrutinib (ACP-196), also known as ACP-196, is an orally available inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, ACP-196 inhibits the activity of BTK and pre... | |||
T29614 | ACP-0052 | SL052,SL 052,SL-052,ACP 0052 | |
ACP-0052(SL-052, ACP-SL-052) is a photosensitizer based on hypoclintin that may be used in the treatment of prostate cancer. | |||
T10240 | ACP-5862 | BTK | |
ACP-5862 is a major active and pyrrolidine ring-opened metabolite of Acalabrutinib (IC50: 5.0 nM for BTK). Acalabrutinib is an irreversible and highly selective BTK inhibitor (IC50: 3 nM; EC50: 8 nM). | |||
TP1837 | Acyl Carrier Protein (ACP) (65-74) | Acyl Carrier Protein (ACP) 65-74 | |
Acyl Carrier Protein (ACP) (65-74) is an active acyl carrier protein (ACP) fragment.Acyl Carrier Protein (ACP) is a component of plastid-located plant fatty acid synthetase. It binds acyl groups covalently via the prosth... | |||
T3484 | Trans-ACPD | Trans-(±)-ACP,1-amino-1,3-dicarboxycyclopentane,(±)-trans-ACPD | GluR |
trans-ACPD ((±)-trans-ACPD) is an equimolecular mixture of (1S, 3R)- and (1R, 3S)-ACPD. trans-ACPD is a selective agonist of the mGluR (metabotropic glutamate receptor); active at the group I/II mGlu receptors (EC50: 2/1... | |||
T34657 | SL-017 | ACPSL-017,S-017,ACP-SL-017,ACP-SL017 | |
SL-017 (ACP-SL-017, ACPSL-017, ACP-SL-017) is a Hypocrellin-B (Hb) derivative and photosensitization agent that may be used to treat abnormal hair growth. SL017 targets the mitochondria and causes the mitochondrial membr... | |||
T71732 | Fmoc-ε-Acp-OH | ||
Fmoc-ε-Acp-OH can be used as a PROTAC linker in the synthesis of PROTACs and other conjugation applications. Fmoc-ε-Acp-OH is an alkane chian with terminal Fmoc-protected amine and carboxylic acid groups. The Fmoc group ... | |||
T70840 | Osemozotan Free Base | ||
Osemozotan Free Base is a 5-HT(1A) receptor agonist. | |||
T4852 | Trimyristin | Trimyristoylglycerol,Tritetradecanoin,Glyceryl trimyristate,1,2,3-Tritetradecanoylglycerol | Phosphatase , Endogenous Metabolite , AChE |
Trimyristin (Tritetradecanoin) is primarily located in the membrane (predicted from logP) and adiposome. glyceryl trimyristate exists in all eukaryotes, ranging from yeast to humans. In humans, glyceryl trimyristate is i... | |||
TP1427L | ReACp53 acetate | p53 | |
ReACp53 acetate could inhibit p53 amyloid formation and rescue p53 function in cancer cell lines. | |||
T75171 | BacPROTAC-1 | ||
BacPROTAC-1, a potent mSA BacPROTAC degrader, exhibits high affinity for both mSA and the N-terminal domain (NTD) of ClpC, with dissociation constants (K D) of 3.9 μM and 2.8 μM, respectively [1]. | |||
T19178 | ACPK | Others | |
ACPK is a pyrrolysine analogue bearing an azide residue. | |||
T70842 | ACP1b | ||
ACP1b is an activator of ClpP protease. | |||
T75168 | Homo-BacPROTAC7 | ||
Homo-BacPROTAC7, a ClpC1 NTD BacPROTAC degrader, targets ClpC2 and efficiently kills M. tuberculosis [1]. | |||
TP1427 | ReACp53 | ||
ReACp53 is a cell-penetrating peptide, designed to inhibit p53 amyloid formation, resues p53 function in cancer cell lines and in organoids derived from high-grade serous ovarian carcinomas (HGSOC). | |||
T75167 | Homo-BacPROTAC6 | ||
Homo-BacPROTAC6, a ClpC1 NTD BacPROTAC degrader, effectively targets ClpC2, while Homo-BacPROTAC7 has been shown to efficiently kill M. tuberculosis [1]. | |||
T22488 | (1S,3R)-ACPD | Others | |
(1S,3R)-ACPD is a group I and II mGlu receptor agonist. |